Robeauté

Executive Summary

Robeauté is a French medical device company pioneering therapeutic microrobots for neurosurgery. Founded in 2017 and based in Paris, the company is developing a modular, rice-sized robotic platform designed to navigate the brain parenchyma to diagnose, treat, and monitor neurological conditions with unprecedented precision. The technology aims to provide surgeons with minimally invasive access to deep brain regions and real-time data, potentially transforming standard neurosurgical procedures. While still in early development stages, Robeauté addresses a critical unmet need in treating brain tumors, hemorrhages, and neurodegenerative diseases. The company has not disclosed funding details or regulatory milestones, but its innovative approach positions it as a notable player in the emerging field of medical microrobotics. Key challenges include proving clinical efficacy, navigating regulatory pathways, and scaling manufacturing. Despite uncertainties, Robeauté's technology holds promise for safer and more effective neurosurgery, attracting interest from investors and strategic partners.

Upcoming Catalysts (preview)

• Q4 2026Initiation of First-in-Human Clinical Trial60% success
• Q3 2026Series B or C Funding Round70% success
• Q2 2026Strategic Partnership with Neurosurgery Device Company50% success